Quote:Darla Shine, Wife of Top Trump Official Bill Shine, Goes on Pro-Measles, Anti-Vax Rant
‘Bring back our #ChildhoodDiseases,’ the former Fox News producer wrote, ‘they keep you healthy & fight cancer.’ Surprise: she’s dangerously wrong.
Tanya Basu
02.13.19 12:16 PM ET
![]()
Photo Illustration by The Daily Beast/Getty
The wife of a top Trump White House official went on an unhinged anti-vaccination Twitter rant Wednesday morning, wrongly suggesting that the deadly measles virus could be beneficial.
https://www.thedailybeast.com/darla-shine-wif...t?ref=home
Darla Shine, a former Fox News producer, is the wife of Bill Shine, a former Fox News executive and current White House deputy chief of staff for communications. Her rant was sparked by a CNN segment on the measles outbreak in Washington and Oregon, which has thus far seen more than 50 unvaccinated individuals contracting the disease.
“Here we go LOL #measlesoutbreak on #CNN,” she wrote in response to the segment. “#Fake #Hysteria.”
“The entire Baby Boom population alive today had the #Measles as kids,” she bizarrely added. “Bring back our #ChildhoodDiseases they keep you healthy & fight cancer.”
The MMR (measles-mumps-rubella) vaccine has been repeatedly proven by scientific circles to be safe and effective against measles, which causes painful rashes that can potentially affect organs and lead to death, particularly among those whose immune systems are compromised.
Nevertheless, Shine doubled down on her anti-vaccination claim, suggesting that her having measles was similar to a child getting chicken pox and gaining lifelong immunity. “I had the #Measles #Mumps #ChickenPox as a child and so did every kid I knew,” she wrote. “Sadly my kids had #MMR so they will never have the life long natural immunity I have. Come breathe on me!”
Shine is correct that having measles as a child protected her from getting the disease again, but she’s wrong that her kids having received the MMR vaccine is “sad.”
Because the disease was eradicated in the U.S. in the early 1990s, people born after that time do not have the immunity to fight the disease. Shine’s children were not only protected from potential death, but also were able to protect others from contracting the disease through herd immunity—or the idea that since most people in a population had the vaccine, they were protected as a “herd.”
In fact, most measles-related deaths are in children under the age of 5 and adults over the age of 30 who are unvaccinated. Measles grants immunity after the disease has passed but can cause serious lifelong issues like blindness, encephalitis (brain swelling), and severe respiratory issues that can lead to pneumonia and death.
After several more tweets accusing her critics of being “trolls” or “Democrat Russian bots,” Shine went so far as to suggest that the measles virus kills cancer.
Shine’s claim that having measles will stave off cancer is completely wrong.
The research she cited was a clinical experiment in which six myeloma patients were given a “concentrated, lab-engineered measles virus,” according to a 2014 story from CNN. In basic terms, the measles virus linked cancer cells together, then exploded, mirroring what the immune system should do but wasn’t done for a cancer patient. The experiment was successful in sending one patient to remission, but the other patients didn’t respond.
The irony? The virus that was given as part of the therapy was structured similarly to a measles vaccine.
Shine’s comments invited immediate scorn from prominent media figures, who noted that a top White House official’s wife was actively spreading anti-vaccination conspiracy theories.
Shine’s comments come at a critical time in the vaccine debate. Just last week, anti-vaxxer Robert F. Kennedy Jr.—nephew of President John F. Kennedy—testified at a Washington state hearing against a bill that would require all entering kindergartners and/or daycare kids to get vaccinated.
This is not the first time Darla Shine has started a national controversy via her social-media accounts. Shortly after her husband was announced in his new Trump role, a bevy of Darla’s racist, sexist, transphobic, or conspiratorial Twitter posts were unearthed.
https://www.vox.com/2018/7/12/17565702/darla-...nti-vaxxer
Darla Shine, Wife of Top Trump Official Bill Shine, Goes
Top 10 Most Recent News Articles
Interventional Ophthalmology: Early Eye Care Strategies Evolve
Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...
Continue Reading
Park Systems Expands in the Pacific Northwest
Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...
Continue Reading
Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table
Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...
Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs
A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...
Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032
It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...
Continue Reading
TECNO CAMON Slim 5G: Where Art Meets Tech
Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...
Continue Reading
Smart City Expo 2026: Innovations in Urban Living
Peeling Back the Layers at Smart City Expo 2026 If you can't feel the pulse of change in urban landscapes, you're about to miss the bus. November's Smart City Expo World Congress (SCEWC) is the stage where cities showcase their flashy new upgrades—not just to look sleek but to make tangible, far-reaching impacts. From November 3 to 5, the city's Gran Via venue will host...
Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results
Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...
Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating
Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...
Continue Reading
Nuix Leverages AI for Transformative Legal Review
Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...
Continue ReadingTop 5 Most Recently Viewed Articles
AlphaSense Drives Healthcare Innovation with AI Insights
AlphaSense Enhances Healthcare Industry Insights The company strengthens its dominance in the industry as the focus shifts to innovation and market trends. As healthcare reaches a pivotal point of transformation, AlphaSense is leading the way with unmatched AI-driven market intelligence. With its advanced search capabilities over a vast trove of high-quality business...
Continue Reading
Intchains Group Limited's ETH Strategy and Financial Update
Intchains Group Limited: A Look Into Their Latest Financial Results As a noteworthy player in the cryptocurrency landscape, Intchains Group Limited (NASDAQ: ICG) recently shared intriguing insights on its financial performance and operational strategies focused on Ethereum (ETH) as of June 30, 2025. This update serves to highlight their advancements in ETH holdings and...
Continue Reading
Krystal Biotech Sets Stage for Stifel 2024 Conference Insights
Krystal Biotech to Attend Stifel 2024 Healthcare Conference Krystal Biotech, Inc. (NASDAQ: KRYS), a notable player in the biotechnology sector, is gearing up to be a part of the Stifel 2024 Healthcare Conference set to take place shortly. The event is highlighted by prominent presentations, including one from Krish S. Krishnan, the Company’s Chairman and Chief Executive...
Continue Reading
The Growth Journey of Cognex: A 15-Year Investment Insight
Understanding the Long-Term Value of Cognex Investments Cognex (NASDAQ: CGNX) has demonstrated remarkable market performance, surpassing the overall market by an impressive 3.2% annually over the past decade and a half. This stellar performance translates to an average annual return of approximately 14.78%. As of now, Cognex holds a market capitalization valued at $9.55...
Continue Reading
Autodesk Inc Reaches New Heights with Stock Performance Surge
Autodesk Inc Achieves Milestone Stock Performance Autodesk Inc. (NASDAQ: ADSK) has marked a significant milestone by reaching a 52-week high at $279.64, reflecting an upward trajectory in its stock performance. Known for its innovative solutions in the fields of architecture, engineering, and construction, Autodesk has become a key player in the software industry. Over...
Continue Reading